The Antalgic Effect of Pulse Frequency and Pad Size of TENS on Blunt Pressure Pain

NCT01999595 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2021-12-22

No results posted yet for this study

Summary

The purpose of this study is to determine the antalgic of surface electrical stimulation with pulse frequencies and pad sizes on blunting pressure pain on healthy human due to various temporal and spatial summations of the stimulation.

Conditions

  • Transcutaneous Electrical Nerve Stimulation
  • Blunt Pressure Pain
  • Pad Size
  • Pulse Frequency
  • Analgesia

Interventions

DEVICE

Control TENS

Control TENS was the application of electrical stimulation via skin with no current

DEVICE

Sham TENS

Sham TENS was the application of electrical stimulation via skin with no current on the participant, who was told "TENS is at a turn-on level whether or not you feel it"

DEVICE

High frequency TENS with large pads

High frequency TENS was delivered on large electrodes

DEVICE

Low frequency TENS with large pads

Low frequency TENS was delivered on large electrodes

DEVICE

High frequency TENS with small pads

High frequency TENS was delivered on small electrodes

DEVICE

Low frequency TENS with small pads

Low frequency TENS was delivered on small electrodes

Sponsors & Collaborators

  • Hung Kaung University

    collaborator OTHER
  • Chang Gung University

    lead OTHER

Principal Investigators

  • Chih Chung Chen, D.Ph. · Chang Gung University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-01
Primary Completion
2013-05-30
Completion
2013-05-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01999595 on ClinicalTrials.gov